Timothy B. Lowinger

2022

In 2022, Timothy B. Lowinger earned a total compensation of $1.2M as Chief Science and Technology Officer at Mersana Therapeutics, a 62% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$209,267
Option Awards$394,197
Salary$450,036
Stock Awards$120,369
Other$7,000
Total$1,180,869

Lowinger received $450K in salary, accounting for 38% of the total pay in 2022.

Lowinger also received $209.3K in non-equity incentive plan, $394.2K in option awards, $120.4K in stock awards and $7K in other compensation.

Rankings

In 2022, Timothy B. Lowinger's compensation ranked 2,714th out of 5,753 executives tracked by ExecPay. In other words, Lowinger earned more than 52.8% of executives.

ClassificationRankingPercentile
All
2,714
out of 5,753
53rd
Division
Manufacturing
1,511
out of 3,133
52nd
Major group
Chemicals And Allied Products
698
out of 1,419
51st
Industry group
Drugs
650
out of 1,320
51st
Industry
Pharmaceutical Preparations
469
out of 966
51st

Pay ratio

Timothy B. Lowinger's Pay$1,180,869
Median Employee's Pay$243,051
Pay Ratio

5

to 1

In 2022, the annual total compensation of Timothy B. Lowinger was $1,180,869.

The annual total compensation of the median employee at Mersana Therapeutics was $243,051.

The ratio of Timothy B. Lowinger's pay to the pay of median employee was therefore 5 to one.

Source: SEC filing on April 28, 2023.

Lowinger's colleagues

We found four more compensation records of executives who worked with Timothy B. Lowinger at Mersana Therapeutics in 2022.

2022

Anna Protopapas

Mersana Therapeutics

Chief Executive Officer

2022

Arvin Yang

Mersana Therapeutics

Chief Medical Officer

2022

Brian DeSchuytner

Mersana Therapeutics

Chief Financial Officer

2022

Alejandra Carvajal

Mersana Therapeutics

Chief Legal Officer

News

You may also like